Atlas Trials

The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients

Clinical trial NCT04799743 · UNKNOWN

Trial details

NCT number
NCT04799743
Sponsor
Hong Kong Baptist University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Covid-19
Start date
2021-04-01
Primary completion
2022-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.